LogoCrystal's Coder Hub

K22.711

10 min read

🧬 ICD-10-CM K22.711 — Barrett’s Esophagus With High Grade Dysplasia

Billable Code Confirmed

ICD-10-CM K22.711 is a valid, billable 6-character ICD-10-CM code for FY2026. The K22 category defines other diseases of the esophagus, the 71 subcategory defines Barrett’s with dysplasia, and the 1 character specifies the dysplasia as high grade. No additional characters are required.

Non-Billable Parent Codes — Never Submit These

  • ❌ K22.7 — 4-character header — Lacks specificity regarding the presence or absence of dysplasia.
  • ❌ K22.71 — 5-character header — Lacks specificity regarding the grade (low vs. high) of the dysplasia.

Always submit K22.711 (all 6 characters) when Barrett’s esophagus with high-grade dysplasia is explicitly documented by the provider.

Clinical Context: The Pre-Malignant Threshold

ICD-10-CM K22.711 captures a critical clinical threshold. High-grade dysplasia (HGD) features severe cellular atypia and is considered the immediate precursor to esophageal adenocarcinoma. It is clinically managed with the same urgency as carcinoma in situ. Accurate coding of this specific character justifies aggressive endoscopic therapies.

Code Classification

ICD-10-CM Diagnosis Code — wRVU, assistant payable, and global period fields are not applicable; direct reader to CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections.

🔍 Code Description

ICD-10 CM K22.711 classifies Barrett’s esophagus with high grade dysplasia. This code represents an advanced precancerous state where the columnar epithelial cells replacing the normal esophageal squamous lining have undergone severe atypical architectural and cytologic changes, though they have not yet invaded the basement membrane.

Pathophysiologically, this condition carries a very high risk of progression to invasive adenocarcinoma (often estimated at 6% or higher per year). Due to this risk, standard “watchful waiting” surveillance is no longer appropriate. Patients with this diagnosis are typically scheduled for Endoscopic Eradication Therapy (EET), such as radiofrequency ablation (RFA) or endoscopic mucosal resection (EMR), to destroy the dysplastic tissue.

🌳 Code Tree / Hierarchy

K22 Other diseases of esophagus ❌ Non-billable
│
├── K22.6 Gastro-esophageal laceration-hemorrhage syndrome ✅ Billable
├── K22.7 Barrett's esophagus ❌ Non-billable
│ │
│ ├── K22.70 Barrett's esophagus without dysplasia ✅ Billable
│ └── K22.71 Barrett's esophagus with dysplasia ❌ Non-billable
│   │
│   ├── K22.710 Barrett's esophagus with low grade dysplasia ✅ Billable
│   ├── K22.711 Barrett's esophagus with high grade dysplasia ◀ THIS CODE ✅ Billable
│   └── K22.719 Barrett's esophagus with dysplasia, unspecified ✅ Billable
│
└── K22.8 Other specified diseases of esophagus ❌ Non-billable

Coding Malignancy Progression

If the pathology report from an endoscopic mucosal resection (EMR) shows that the high-grade dysplasia has breached the basement membrane and invaded the lamina propria, the diagnosis has crossed into malignancy. In that scenario, you must stop using K22.711 and begin coding C15.- (Malignant neoplasm of esophagus).

✅ Includes

The following clinical terms and scenarios map to K22.711 when documented:

  • Barrett’s esophagus with severe dysplasia

  • High-grade dysplasia arising in Barrett’s mucosa

  • Carcinoma in situ of Barrett’s esophagus (often clinically cross-mapped here or to D00.1; consult facility guidelines)

  • HGD of the distal esophagus with intestinal metaplasia

❌ Excludes

Excludes 1 — Cannot Be Coded Simultaneously with K22.711

CodeDescriptionNote
K22.70Barrett’s esophagus without dysplasiaMutually exclusive. Code the highest severity present; the high-grade dysplasia completely supersedes non-dysplastic Barrett’s.
K22.710Barrett’s esophagus with low grade dysplasiaMutually exclusive. If a patient has multiple biopsies showing both low and high grade, code only the highest grade (K22.711).
C15.-Malignant neoplasm of esophagusMutually exclusive. If the condition has progressed to invasive adenocarcinoma, only the cancer code is reported.

Excludes 1 Violation Risk

A common error occurs when coders attempt to assign multiple Barrett’s codes (e.g., K22.70 and K22.711) because different biopsies from the same procedure yielded different results. ICD-10-CM rules dictate capturing only the most severe histologic grade for the anatomical site.

Excludes 2 — May Be Coded in Addition if Separately Present

CodeDescriptionNote
K21.-Gastro-esophageal reflux diseaseMay be coded simultaneously. Since GERD is the primary underlying etiology that drives the metaplastic and dysplastic changes, both should be coded if actively managed.

📋 Clinical Overview

Phenotype Distinction: Barrett’s Progression Risk

This table illustrates why specific dysplasia capture is vital, as it directly alters the clinical treatment pathway and medical necessity for interventions.

FeatureK22.70 — Without DysplasiaK22.710 — Low Grade DysplasiaK22.711 — High Grade Dysplasia
Cellular ArchitectureIntestinal metaplasia onlyMild atypical cellular changesSevere atypia, architectural distortion
Cancer RiskVery LowModerateHigh (Pre-malignant)
Typical ManagementEGD Surveillance (every 3-5 years)EGD Surveillance (annual) or AblationEndoscopic Eradication Therapy (RFA/EMR) or Esophagectomy

Documentation Tip — "Suspected" vs "Confirmed"

You cannot assign K22.711 based on an endoscopist’s visual suspicion of HGD during the procedure (e.g., “nodule highly suspicious for HGD”). Dysplasia is a histologic diagnosis. You must wait for the final pathology report, and the provider must link the pathology finding to their final diagnosis before coding K22.711.

Manifestations & Symptom Burden

High-grade dysplasia itself does not cause unique symptoms distinct from standard GERD or Barrett’s, but progressive symptoms may indicate an impending malignancy:

  • Dysphagia: Difficulty swallowing; may suggest a nodular lesion or stricture forming.

  • Odynophagia: Painful swallowing.

  • Intractable Heartburn: Severe GERD symptoms that resist high-dose PPI therapy.

Coding Manifestations

Always code the documented underlying conditions to fully capture the patient’s complexity. Examples include:

  • K21.00 — Gastro-esophageal reflux disease with esophagitis, without bleeding

  • K22.2 — Esophageal obstruction (if a stricture is present)

💰 HCC Risk Adjustment (CMS-HCC v28)

FieldDetail
CMS-HCC Model Versionv28 (2024-2025 Implementation)
HCC Assignment❌ Not HCC-Mapped
HCC CategoryN/A
RAF CoefficientN/A

K22.711 does not map directly to a payment HCC under v28.

Capture Annually

Even though it doesn’t map to a payment HCC, this is a critical code for quality metrics and prior authorizations. It proves the medical necessity for high-frequency EGDs (sometimes every 3 months) and highly expensive ablative therapies that payers would instantly deny if billed with standard GERD or non-dysplastic Barrett’s codes.

🏥 DRG Assignment

MDC 06 — Diseases and Disorders of the Digestive System

DRGTitleEst. Relative Weight*
DRG 391Esophagitis, Gastroenteritis and Misc Digestive Disorders with MCC~1.15
DRG 392Esophagitis, Gastroenteritis and Misc Digestive Disorders without MCC~0.70

Approximate. Verify against IPPS FY2026 Final Rule tables.

Sequencing and Complications

When K22.711 is sequenced as a principal diagnosis, it groups to the Esophagitis/Misc Digestive DRGs (391/392). It is most commonly seen as a principal diagnosis for a planned inpatient admission to perform a complex endoscopic mucosal resection (EMR) of a nodule in a patient with high comorbidities. It does not act as a CC or MCC.

🔗 Related ICD-10-CM Codes

Progression / Exacerbation Variants

CodeDescription
K22.70Barrett’s esophagus without dysplasia
K22.710Barrett’s esophagus with low grade dysplasia
K22.711Barrett’s esophagus with high grade dysplasia ← This Code

Etiology and Malignant Transformation

CodeDescription
[[K21.9]]Gastro-esophageal reflux disease without esophagitis
D00.1Carcinoma in situ of esophagus (Alternative/overlap dependent on specific path phrasing)
C15.5Malignant neoplasm of lower third of esophagus (Invasive cancer)

🛠️ Commonly Associated CPT Codes (Outpatient & Profee)

Outpatient and Profee Setting Context

In the GI specialty, K22.711 is heavily associated with therapeutic/interventional endoscopies, specifically aimed at destroying the dysplastic tissue to prevent esophageal cancer.

CPT CodeDescriptionProfee Coding Notes (Modifier 26)
43229EGD, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s)Billed for Radiofrequency Ablation (RFA) or Cryotherapy of HGD.
43211EGD, flexible, transoral; with endoscopic mucosal resection (EMR)Billed when a distinct nodular area of HGD is resected for pathology.
43239EGD, flexible, transoral; with biopsy, single or multipleUsed for follow-up surveillance mapping post-ablation.

NCCI Bundling Considerations

  • 43239 (Biopsy) billed on the same day as 43229 (Ablation). If the provider biopsies the HGD lesion and then ablates the same lesion during the same encounter, NCCI bundles the biopsy into the ablation. If a separate, distinct lesion is biopsied, you may report 43239 with Modifier -59.

🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)

When K22.711 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient interventions.

PCS SectionBody SystemRoot OperationClinical Application
0 (Medical/Surgical)D (Gastrointestinal System)5 (Destruction)Radiofrequency ablation of HGD in the distal esophagus: 0D558ZZ (Destruction of Lower Esophagus, Via Natural or Artificial Opening Endoscopic).
0 (Medical/Surgical)D (Gastrointestinal System)B (Excision)Endoscopic mucosal resection (EMR) of a dysplastic nodule: 0DB58ZZ (Excision of Lower Esophagus, Via Natural or Artificial Opening Endoscopic).

💊 Coding Scenarios and Examples

Scenario 1 — Ambulatory Surgery Center: Therapeutic Intervention

Clinical Vignette: A 64-year-old male with a known history of Barrett’s esophagus with high-grade dysplasia presents for planned endoscopic eradication therapy. The provider advances the endoscope and identifies the 4 cm segment of dysplastic Barrett’s mucosa. Using a balloon-based radiofrequency ablation (RFA) catheter, the entire segment is successfully ablated. No complications.

CPT / HCPCS (Profee):

  • 43229 — EGD, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (Captures the RFA).

ICD-10-CM Diagnoses:

  • K22.711 — Barrett’s esophagus with high grade dysplasia (The exact indication for the ablative therapy).

Scenario 2 — Inpatient Hospitalization: Post-Procedural Complication

Clinical Vignette: A 70-year-old female undergoes an outpatient EMR for Barrett’s with high-grade dysplasia. Six hours post-procedure, she presents to the ED with severe hematemesis. She is admitted to the inpatient unit for an acute GI bleed. An emergent repeat EGD reveals active bleeding at the EMR resection site in the distal esophagus, which is successfully controlled with epinephrine injection and clipping.

Principal Diagnosis:

  • K91.840 — Postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure (Reason for admission/complication).

Secondary Diagnoses:

  • K22.711 — Barrett’s esophagus with high grade dysplasia (The underlying condition that necessitated the initial procedure).

MS-DRG Assignment: Groups to DRG 919 (Complications of Treatment with MCC) or 920/921 (depending on secondary MCCs like acute blood loss anemia). K22.711 serves as necessary clinical context but does not elevate the DRG weight.

Scenario 3 — CDI Query: Bridging Pathology to Diagnosis

Clinical Vignette: A patient follows up in the GI clinic 2 weeks after an EGD mapping for known Barrett’s esophagus. The provider’s assessment simply states: “Barrett’s esophagus. Will schedule for RFA next month.” The attached pathology report from the mapping biopsies reads: “Distal esophagus mucosa: Intestinal metaplasia with high-grade dysplasia.”

Action / Outcome:

If coded strictly from the provider’s final assessment (“Barrett’s esophagus”), the coder would be forced to use K22.70 (without dysplasia), which would likely result in an insurance denial for the upcoming RFA procedure due to lack of medical necessity. A query must be sent to the provider to incorporate the pathology findings into the official diagnosis.

Query Response: Provider updates the clinical assessment to state: “Barrett’s esophagus with high-grade dysplasia confirmed on path. Justifies need for RFA.”

Corrected ICD-10-CM Coding:

  • K22.711 — Barrett’s esophagus with high grade dysplasia (Accurately reflects the pathology and secures medical necessity for the intervention).

⚠️ Coding Pitfalls and Tips

Pitfall or Tip
❌Coding HGD as Invasive Cancer. High-grade dysplasia is pre-malignant (equivalent to carcinoma in situ). Do not assign C15.- (Malignant neoplasm of esophagus) unless the pathology explicitly states invasive adenocarcinoma.
❌Coding Multiple Dysplasia Grades. If a pathology report shows both low-grade and high-grade dysplasia in different biopsies from the same Barrett’s segment, do not code both. You must code only K22.711 to capture the highest severity.
✅Query for Vague Dysplasia. If the provider documents “Barrett’s with dysplasia” but fails to specify the grade (low vs. high), query the provider or reference the pathology report to clarify. Only use K22.719 (Unspecified) as a last resort.
✅Review Pre-Auth Requirements. K22.711 is one of the few GI diagnoses that almost universally justifies the medical necessity for therapeutic ablations like RFA (CPT 43229). Ensure this code is the primary diagnosis linked to the therapeutic CPT on the claim form.

📚 Sources

  1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026.

  2. American Society for Gastrointestinal Endoscopy (ASGE). Guidelines for the Management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma.

  3. CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 06 logic tables.

  4. AMA. CPT Professional Edition 2026. Surgery / Digestive System.

Graph View

Recent Notes